BANK OF MONTREAL /CAN/ - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 112 filers reported holding REVANCE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.7%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$255,212
-79.8%
14,210
-67.0%
0.00%
Q2 2023$1,265,399
+105.1%
43,077
+122.2%
0.00%
Q2 2021$617,000
-11.5%
19,385
-22.9%
0.00%
Q1 2021$697,000
-45.9%
25,153
-43.5%
0.00%
-100.0%
Q4 2020$1,289,000
-33.8%
44,534
-41.7%
0.00%
-50.0%
Q3 2020$1,948,000
+205.8%
76,404
+204.2%
0.00%
+100.0%
Q2 2020$637,000
+128.3%
25,118
+23.0%
0.00%
Q1 2020$279,000
-14.7%
20,414
+1.2%
0.00%
Q4 2019$327,000
+151.5%
20,168
+101.2%
0.00%
Q3 2019$130,000
-3.0%
10,026
-2.7%
0.00%
Q2 2019$134,000
+162.7%
10,301
+217.7%
0.00%
Q1 2019$51,000
-26.1%
3,242
-6.4%
0.00%
Q4 2018$69,000
-14.8%
3,465
+7.4%
0.00%
Q3 2018$81,000
+1250.0%
3,227
+1285.0%
0.00%
Q2 2018$6,000
+200.0%
233
+219.2%
0.00%
Q4 2015$2,000
-66.7%
73
-57.1%
0.00%
Q2 2014$6,0001700.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders